159891 医疗
已收盘 06-12 15:00:00
资讯
新帖
简况
金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务
智通财经 · 06-12 21:15
金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务
凯普生物：主要包含公司在一季度对非夕科技、深圳镜象科技有限公司及深圳赛陆医疗科技有限公司支付的股权投资款项
证券之星 · 06-12 20:52
凯普生物：主要包含公司在一季度对非夕科技、深圳镜象科技有限公司及深圳赛陆医疗科技有限公司支付的股权投资款项
立足核医疗、氢能等细分领域 江西九江“落子”未来产业
中国新闻网 · 06-12 16:22
立足核医疗、氢能等细分领域 江西九江“落子”未来产业
泰凌医药2025年报被出具“不发表意见”后 续聘大华决议遭96.62%高票否决 AI医疗故事尚未贡献一分钱收入
新浪证券 · 06-12 11:01
泰凌医药2025年报被出具“不发表意见”后 续聘大华决议遭96.62%高票否决 AI医疗故事尚未贡献一分钱收入
Viking Therapeutics任命Hubert C. Chen博士为新任首席医疗官
环球市场播报 · 06-11 23:06
Viking Therapeutics任命Hubert C. Chen博士为新任首席医疗官
轻松健康携手巴塞尔医疗 AI医疗服务出海迈出关键一步
证券日报 · 06-11 19:09
轻松健康携手巴塞尔医疗 AI医疗服务出海迈出关键一步
鸿远电子：公司自产业务民品面向通信、工业、医疗电子、汽车电子、轨道交通等民用高端领域
证券之星 · 06-11 17:51
鸿远电子：公司自产业务民品面向通信、工业、医疗电子、汽车电子、轨道交通等民用高端领域
广东省特检院阳江检测院精准施检守护妇幼医疗电梯安全
中国质量新闻网 · 06-11 17:12
广东省特检院阳江检测院精准施检守护妇幼医疗电梯安全
华邦健康：张一卓在华邦旗下医疗事业部任执行董事
证券之星 · 06-11 16:12
华邦健康：张一卓在华邦旗下医疗事业部任执行董事
启明创投胡旭波：医疗创新处于目前市场估值体系底部
睿见Economy · 06-11 11:51
启明创投胡旭波：医疗创新处于目前市场估值体系底部
汉诺医疗“零突破”B面：增收难盈利，膜材依赖独供、产能不饱和要扩产
证券之星 · 06-11 10:15
汉诺医疗“零突破”B面：增收难盈利，膜材依赖独供、产能不饱和要扩产
爱尔眼科：长期向头部集中是因为患者对医疗品质的需求是没有上限的
证券之星 · 06-11 08:51
爱尔眼科：长期向头部集中是因为患者对医疗品质的需求是没有上限的
调查显示：半数美国人向AI寻求医疗建议，多数人信任AI给出的指导
环球市场播报 · 06-10 23:59
调查显示：半数美国人向AI寻求医疗建议，多数人信任AI给出的指导
西格玛医疗洽谈收购英国博姿药房，尚处初步磋商阶段
环球市场播报 · 06-10 23:22
西格玛医疗洽谈收购英国博姿药房，尚处初步磋商阶段
轻松健康(02661)与巴塞尔医疗订立战略合作备忘录 以实现技术输出与技术迭代双向发展
智通财经 · 06-10 19:02
轻松健康(02661)与巴塞尔医疗订立战略合作备忘录 以实现技术输出与技术迭代双向发展
西格玛医疗洽谈收购英国博姿药房
环球市场播报 · 06-10 17:09
西格玛医疗洽谈收购英国博姿药房
久远银海：聚焦医疗医保、数字政务和智慧城市三大业务方向
证券之星 · 06-10 15:54
久远银海：聚焦医疗医保、数字政务和智慧城市三大业务方向
慈善力量“补位”医疗救助，“和敏健康”援助金额超1600万
中国新闻网 · 06-10 10:53
慈善力量“补位”医疗救助，“和敏健康”援助金额超1600万
Citrini看多美股医疗板块新行情，更新“卖铲人”篮子：AI利好叠加周期性改善，复苏信号更明确
中金财经 · 06-10 10:17
Citrini看多美股医疗板块新行情，更新“卖铲人”篮子：AI利好叠加周期性改善，复苏信号更明确
Citrini看多美股医疗板块新行情，更新“卖铲人”篮子：AI利好叠加周期性改善，复苏信号更明确
智通财经 · 06-10 09:49
Citrini看多美股医疗板块新行情，更新“卖铲人”篮子：AI利好叠加周期性改善，复苏信号更明确
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159891","market":"SZ","secType":"STK","nameCN":"医疗","latestPrice":0.377,"timestamp":1781247813000,"preClose":0.372,"halted":0,"volume":27156401,"delay":0,"changeRate":0.0134,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.005,"latestTime":"06-12 15:00:00","open":0.373,"high":0.379,"low":0.372,"amount":10165900,"amplitude":0.0188,"askPrice":0.378,"askSize":4488,"bidPrice":0.377,"bidSize":1776,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"adjPreClose":0.372,"symbolType":"fund","openAndCloseTimeList":[[1781227800000,1781235000000],[1781240400000,1781247600000]],"highLimit":0.409,"lowLimit":0.335,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":-0.074981,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/159891","defaultTab":"news","newsList":[{"id":"2642295697","title":"金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2642295697","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642295697?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:15","pubTimestamp":1781270135,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金域医学(603882.SH)发布公告，公司拟使用自有资金与广州市圣域钫投资咨询合伙企业(有限合伙)等公司共同投资设立广州金坤医智科技有限公司(简称“金坤医智”，暂定名)，注册资本5000万元。其中，公司认缴出资1000万元，持股比例为20%。金坤医智核心业务将聚焦“智慧医疗”，基于对医疗全场景的深度洞察，整合自研AI产品与生态伙伴资源，为医院、药企、保险、IVD厂商等多元客户提供医疗数智化综合解决方案及端到端全流程数智化服务，金坤医智的业务定位与公司主营业务形成互补协同、差异发展，有助于拓展公司在智慧医疗领域的战略布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0284","BK0042","SG9999001069.SGD","BK0236","603882","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642939342","title":"凯普生物：主要包含公司在一季度对非夕科技、深圳镜象科技有限公司及深圳赛陆医疗科技有限公司支付的股权投资款项","url":"https://stock-news.laohu8.com/highlight/detail?id=2642939342","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642939342?lang=zh_cn&edition=full","pubTime":"2026-06-12 20:52","pubTimestamp":1781268741,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司2026一季度“投资支付的现金”为 2.03亿元，较去年同期的1.16亿元增长了约74.74%。公司2026年一季度“投资支付的现金”同比增长74.74%，主要系本期对外支付投资款增加所致。该科目支出除常规理财购买外，主要包含公司在一季度对非夕科技、深圳镜象科技有限公司及深圳赛陆医疗科技有限公司支付的股权投资款项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200036094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300639","BK0042","159891","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642265381","title":"立足核医疗、氢能等细分领域 江西九江“落子”未来产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2642265381","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642265381?lang=zh_cn&edition=full","pubTime":"2026-06-12 16:22","pubTimestamp":1781252520,"startTime":"0","endTime":"0","summary":"据了解，“十五五”时期，江西九江“落子”未来产业，立足核医疗、氢能、低空经济、人工智能等细分领域，全力培育新增长点。6月12日，由江西省政府新闻办举行的九江专场“高标准高质量建设长江经济带重要节点城市”新闻发布会在南昌举行。“十五五”时期，九江明确“重要节点城市建设迈出新步伐、科技创新能力实现新跃升”等7大主要目标，提出到“十五五”末，地区生产总值突破5000亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-06-12/doc-iniccwvr0221290.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-12/doc-iniccwvr0221290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HYDR","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642259548","title":"泰凌医药2025年报被出具“不发表意见”后 续聘大华决议遭96.62%高票否决 AI医疗故事尚未贡献一分钱收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2642259548","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642259548?lang=zh_cn&edition=full","pubTime":"2026-06-12 11:01","pubTimestamp":1781233260,"startTime":"0","endTime":"0","summary":"2026年6月4日，港股泰凌医药召开股东周年大会，一项看似常规的“重新委任核数师”的决议案引发轩然大波。最终投票结果显示，关于重新委任大华马施云会计师事务所有限公司为公司核数师的第3项普通决议案，赞成票仅为7，253，850股，反对票高达207，054，239股，以大比例被否决。这是泰凌医药近年最激烈的一次“以票否决”式治理事件。 大华马施云会计师事务所有限公司已自股东周年大会结束时起退任公司核数师。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-06-12/doc-iniccfxx0342889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891","AGIX","AIPO","ARTY","BK1191","01011","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642382782","title":"Viking Therapeutics任命Hubert C. Chen博士为新任首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=2642382782","media":"环球市场播报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642382782?lang=zh_cn&edition=full","pubTime":"2026-06-11 23:06","pubTimestamp":1781190360,"startTime":"0","endTime":"0","summary":"临床阶段生物制药公司Viking Therapeutics周四宣布，任命Hubert C． Chen博士为首席医疗官。Chen博士将负责领导公司的临床开发、医学及监管事务，直接向公司总裁兼首席执行官Brian Lian博士汇报。在加入Viking之前，他曾担任Loyal Animal Health的首席研发官，领导了首个与美国食品药品监督管理局达成谈判的长寿疗法有效性和安全性要求制定工作。 这一任命正值Viking推进其核心候选药物VK2735的关键时期。Viking还计划于本季度启动新型胰淀素激动剂VK3019的一期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-11/doc-inicaenm0642884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","BK4539","LENZ","BK4139","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642828904","title":"轻松健康携手巴塞尔医疗 AI医疗服务出海迈出关键一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2642828904","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642828904?lang=zh_cn&edition=full","pubTime":"2026-06-11 19:09","pubTimestamp":1781176140,"startTime":"0","endTime":"0","summary":"本报讯（记者矫月）近日，轻松健康集团（以下简称“轻松健康”）与BaselMedicalGroupLtd（以下简称“巴塞尔医疗”）宣布签署战略合作备忘录。双方将基于轻松健康集团的AIcare技术栈及旗下循证医学智能体“证元芳·MedClaw协作体”，结合巴塞尔医疗在东南亚的专科医疗场景与企业客户网络，围绕AI医疗服务升级、保险价值链赋能及跨境医疗服务等方向展开合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606113768476412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["AGIX","BK1219","159891","AIPO","02661","ARTY","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642836952","title":"鸿远电子：公司自产业务民品面向通信、工业、医疗电子、汽车电子、轨道交通等民用高端领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2642836952","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642836952?lang=zh_cn&edition=full","pubTime":"2026-06-11 17:51","pubTimestamp":1781171470,"startTime":"0","endTime":"0","summary":"证券之星消息，鸿远电子(603267)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：公司军工央企的订单一直占比非常高，更加广阔的民用领域，订单很少。公司定位产品应用于高端民用领域，现在向哪个高端民用领域大批量供货？是否因为军工领域订单较为稳定，可以维持公司稳定运行，所以管理层对拓展民用市场并不在意？鸿远电子回复：尊敬的投资者您好，公司自产业务民品面向通信、工业、医疗电子、汽车电子、轨道交通等民用高端领域。公司推动高可靠产品和民用产品协同发展，稳步拓展民用应用市场。谢谢。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100028379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603267","159891","BK0214"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642591283","title":"广东省特检院阳江检测院精准施检守护妇幼医疗电梯安全","url":"https://stock-news.laohu8.com/highlight/detail?id=2642591283","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642591283?lang=zh_cn&edition=full","pubTime":"2026-06-11 17:12","pubTimestamp":1781169120,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 近日，广东省特种设备检测研究院阳江检测院组织机电检验骨干，对阳江市妇幼保健院在用电梯开展全面检验，以专业技术守护民生医疗安全。下一步阳江检测院将持续聚焦医疗机构、大型商超、老旧小区、教育机构等重点场所特种设备安全，深化“主动服务、精准保障”工作理念，以常态化检验与专业化指导，为阳江民生领域特种设备安全平稳运行保驾护航。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-06-11/doc-iniazpqr4062815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642240758","title":"华邦健康：张一卓在华邦旗下医疗事业部任执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2642240758","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642240758?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:12","pubTimestamp":1781165545,"startTime":"0","endTime":"0","summary":"证券之星消息，华邦健康(002004)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问张松山之子张一卓在华邦系旗下任什么职务，2024年和2025年的年薪分别是多少？华邦健康回复：投资者您好，张一卓在华邦旗下医疗事业部任执行董事，感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100024788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","159891","BK0114","BK0229","BK0188","BK0174","BK0146","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642403086","title":"启明创投胡旭波：医疗创新处于目前市场估值体系底部","url":"https://stock-news.laohu8.com/highlight/detail?id=2642403086","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642403086?lang=zh_cn&edition=full","pubTime":"2026-06-11 11:51","pubTimestamp":1781149860,"startTime":"0","endTime":"0","summary":" 2026投资界SuperLink大会于6月10日-6月11日在苏州举行。启明创投主管合伙人胡旭波表示，目前AI是一个最大的投资主题，不管是创业者还是LP，大量的注意力都流向AI，这是好事情，我个人也认为AI对未来十年投资而言是很重要的因素。 他介绍，启明创投在医疗创新领域的三大核心布局方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-06-11/doc-iniazays5573453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642408848","title":"汉诺医疗“零突破”B面：增收难盈利，膜材依赖独供、产能不饱和要扩产","url":"https://stock-news.laohu8.com/highlight/detail?id=2642408848","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642408848?lang=zh_cn&edition=full","pubTime":"2026-06-11 10:15","pubTimestamp":1781144141,"startTime":"0","endTime":"0","summary":"汉诺医疗认为，随着主要产品的商业化推进及其他新产品的陆续上市，预计公司经营亏损将逐步收窄并实现盈利，中性预测预计2028年实现盈亏平衡。“零突破”背后的核心原材料依赖据汉诺医疗介绍，Lifemotion ECMO系统获批上市之前，全球仅美、德、意等少数国家具备该产品产业化能力。2023年Solventum为汉诺医疗第二大原材料供应商、2024年、2025年跃居榜首。证券之星注意到，募投项目中，汉诺医疗生产基地建设项目为扩产项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026061100009901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642477586","title":"爱尔眼科：长期向头部集中是因为患者对医疗品质的需求是没有上限的","url":"https://stock-news.laohu8.com/highlight/detail?id=2642477586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642477586?lang=zh_cn&edition=full","pubTime":"2026-06-11 08:51","pubTimestamp":1781139085,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科06月11日在投资者关系平台上答复投资者关心的问题。“局部集中”，是普遍现象，各地头两三家医疗机构占据了大部分市场份额。“长期向头部集中”，是因为患者对医疗品质的需求是没有上限的，信息透明、交通便利、医保互通更加剧了这种长期趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100004893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0114","BK0200","LU0979878070.USD","LU1820825898.SGD","159891","BK0113","BK0188","LU1242518857.USD","300015","BK0096","BK0077","LU1146622755.USD","BK0196","LU1242518931.SGD","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642427143","title":"调查显示：半数美国人向AI寻求医疗建议，多数人信任AI给出的指导","url":"https://stock-news.laohu8.com/highlight/detail?id=2642427143","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642427143?lang=zh_cn&edition=full","pubTime":"2026-06-10 23:59","pubTimestamp":1781107140,"startTime":"0","endTime":"0","summary":"eHealth最新发布的调查数据显示，人工智能正日益成为美国人寻求医疗建议的重要渠道。在参与调查的1000多名美国受访者中，有49%的人表示曾使用AI工具获取医疗建议，其中高达82%的人表示信任AI提供的信息。这一数据揭示了AI在医疗健康领域日益增长的影响力，以及公众对AI医疗建议接受度的显著提升。调查同时发现，53%的投保美国人在过去12个月内曾因费用问题而避免就医，56%的人在过去五年中至少跳过一年次的年度健康检查。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-10/doc-iniaxzpe5768720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIPO","AGIX","ARTY","159891","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642422014","title":"西格玛医疗洽谈收购英国博姿药房，尚处初步磋商阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2642422014","media":"环球市场播报","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642422014?lang=zh_cn&edition=full","pubTime":"2026-06-10 23:22","pubTimestamp":1781104920,"startTime":"0","endTime":"0","summary":"私募公司西科莫尔去年收购母公司沃尔格林联合博姿集团，从而拿下博姿控制权。 澳大利亚西格玛医疗正就潜在收购英国连锁药房博姿开展早期洽谈。 澳洲药企西格玛医疗发布公告称，公司正在推进早期磋商，拟收购英国连锁药房博姿，以此寻求本土市场之外的业务扩张。西格玛将收购多家门店 75% 的股权。他称，与绿光医疗的合资布局将让公司 “稳步切入英国市场”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-10/doc-iniaxzpe5750098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428127","title":"轻松健康(02661)与巴塞尔医疗订立战略合作备忘录 以实现技术输出与技术迭代双向发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428127","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642428127?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:02","pubTimestamp":1781089358,"startTime":"0","endTime":"0","summary":"双方一致认为，将集团经验证的健康AI基础设施，与巴塞尔医疗在东南亚的临床场景及市场入口相结合，有助于推动区域医疗服务的智能化升级，并为双方共同开拓新的市场机会。双方拟以集团Alcare技术栈为基础，支持巴塞尔医疗在东南亚地区开展AI-native的医疗服务升级，并共同拓展区域市场，建立长期、稳定的战略合作关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02661","BK1219","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642295444","title":"西格玛医疗洽谈收购英国博姿药房","url":"https://stock-news.laohu8.com/highlight/detail?id=2642295444","media":"环球市场播报","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642295444?lang=zh_cn&edition=full","pubTime":"2026-06-10 17:09","pubTimestamp":1781082540,"startTime":"0","endTime":"0","summary":"私募股权公司锡卡莫尔集团去年收购母公司沃尔格林博姿联合公司，从而取得博姿药房控制权。 澳大利亚西格玛医疗正就收购英国连锁药房博姿开展早期洽谈。 澳大利亚药企西格玛医疗发布公告称，公司正在推进初步磋商，拟收购英国连锁药房博姿，以此拓展海外市场版图。 受消息影响，西格玛医疗在悉尼交易所收盘股价下跌 5.5%。他称，本次与绿光医疗组建合资企业，将帮助集团 “稳妥布局英国市场”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-10/doc-iniaxkrn5902260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642372446","title":"久远银海：聚焦医疗医保、数字政务和智慧城市三大业务方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2642372446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642372446?lang=zh_cn&edition=full","pubTime":"2026-06-10 15:54","pubTimestamp":1781078050,"startTime":"0","endTime":"0","summary":"证券之星消息，久远银海(002777)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司有机器人应用研发吗？通过实体服务机器人提升客户场景的智能化体验，以及通过软件RPA机器人强化其解决方案的自动化能力与竞争力。久远银海回复：尊敬的投资者您好！公司聚焦医疗医保、数字政务和智慧城市三大业务方向，持续推动技术研发创新与场景应用。相关情况详见公司披露的2025年年度报告。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000024814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","002777","159891","BK0037","BK0132","BK0231","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642414352","title":"慈善力量“补位”医疗救助，“和敏健康”援助金额超1600万","url":"https://stock-news.laohu8.com/highlight/detail?id=2642414352","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642414352?lang=zh_cn&edition=full","pubTime":"2026-06-10 10:53","pubTimestamp":1781059980,"startTime":"0","endTime":"0","summary":"截至2026年5月，安踏集团和敏基金会“和敏健康援助”项目已累计援助困难群众超1600人，发放援助资金超1600万元。这一由非公募基金会在政务服务中心设立专属窗口、开展“补位式”医疗救助的创新实践，帮助一个个陷入困境的家庭重获生活的底气。2022年11月，基金会正式在晋江市政务服务中心启动“和敏健康”援助项目，并设立专属慈善救助窗口。项目坚持以政府救助为主导、慈善基金会补位，计划五年投入5000万元专项援助资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-06-10/doc-iniawttx4609258.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-10/doc-iniawttx4609258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642120411","title":"Citrini看多美股医疗板块新行情，更新“卖铲人”篮子：AI利好叠加周期性改善，复苏信号更明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2642120411","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642120411?lang=zh_cn&edition=full","pubTime":"2026-06-10 10:17","pubTimestamp":1781057821,"startTime":"0","endTime":"0","summary":"Citrini Research近日对其医疗保健投资组合进行了更新，原因是该公司对生命科学、生物加工及医疗基础设施板块的复苏愈发乐观。这一复苏既受周期性改善推动，也受益于AI相关利好因素的支持。Citrini认为，这些公司有望从生物技术融资回暖、制药领域并购活动升温以及AI在药物研发中加速应用等趋势中获益。 该组合体现了Citrini对医疗健康生态系统中“卖铲人”策略的偏好，而非更具投机性、由AI驱动的生物科技个股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260610/32275161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["AIPO","AGIX","CHAT","ARTY","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642411874","title":"Citrini看多美股医疗板块新行情，更新“卖铲人”篮子：AI利好叠加周期性改善，复苏信号更明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2642411874","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642411874?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:49","pubTimestamp":1781056155,"startTime":"0","endTime":"0","summary":"Citrini认为，这些公司有望从生物技术融资回暖、制药领域并购活动升温以及AI在药物研发中加速应用等趋势中获益。该组合体现了Citrini对医疗健康生态系统中“卖铲人”策略的偏好，而非更具投机性、由AI驱动的生物科技个股。Citrini此前指出，丹纳赫旗下Cytiva部门的生物加工设备订单在2026年第一季度同比增长超过30%;而Repligen已连续三个季度实现营收两位数增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","AGIX","ARTY","AIPO","159891"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781314874353,"stockEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":-0.1293},{"period":"3month","weight":-0.1509},{"period":"6month","weight":-0.1273},{"period":"1year","weight":-0.1293},{"period":"ytd","weight":-0.1192}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0158}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医疗(159891)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医疗(159891)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医疗,159891,医疗股票,医疗股票老虎,医疗股票老虎国际,医疗行情,医疗股票行情,医疗股价,医疗股市,医疗股票价格,医疗股票交易,医疗股票购买,医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医疗(159891)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医疗(159891)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}